The KDIGO bundle involves the discontinuation of nephrotoxic agents and angiotensin-converting enzyme inhibitors, close hemodynamic and creatinine monitoring, and avoidance of hyperglycemia. The gene discussed is ACE; the disease is Hyperglycemia.